Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

被引：0
|
作者：
Xia Xu
Fei Deng
Mengmeng Lv
Binhui Ren
Wenwen Guo
Xiaoxiang Chen
机构：
[1] Department of Chemotherapy,
[2] Jiangsu Cancer Hospital,undefined
[3] Department of Gynecologic Oncology,undefined
[4] Jiangsu Cancer Hospital,undefined
[5] Department of Thoracic Oncology,undefined
[6] Jiangsu Cancer Hospital,undefined
[7] The Second Affiliated Hospital of Nanjing Medical University,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
High grade serous ovarian cancer; CA-125; Ascites; Primary debulking surgery; Interval debulking surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Ovarian Cancer Response Scoring (OCRS): Validation of a system to quantify histopathological response to neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Singh, N.
    Said, I.
    Faruqi, A.
    Gilks, B.
    Le, N.
    Boehm, S.
    VIRCHOWS ARCHIV, 2014, 465 : S40 - S40
  • [32] Survival of patients with stage IV high-grade serous ovarian cancer treated with intraperitoneal versus intravenous platinum-based chemotherapy
    Alharbi, Hamad
    Kim, Soyoun Rachel
    Maganti, Manjula
    May, Taymaa
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S247 - S247
  • [33] Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Rundo, Leonardo
    Beer, Lucian
    Escudero Sanchez, Lorena
    Crispin-Ortuzar, Mireia
    Reinius, Marika
    McCague, Cathal
    Sahin, Hilal
    Bura, Vlad
    Pintican, Roxana
    Zerunian, Marta
    Ursprung, Stephan
    Allajbeu, Iris
    Addley, Helen
    Martin-Gonzalez, Paula
    Buddenkotte, Thomas
    Singh, Naveena
    Sahdev, Anju
    Funingana, Ionut-Gabriel
    Jimenez-Linan, Mercedes
    Markowetz, Florian
    Brenton, James D.
    Sala, Evis
    Woitek, Ramona
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients
    Sokolenko, Anna P.
    Gorodnova, Tatiana, V
    Bizin, Ilya, V
    Kuligina, Ekaterina Sh
    Kotiv, Khristina B.
    Romanko, Alexandr A.
    Ermachenkova, Tatiana, I
    Ivantsov, Alexandr O.
    Preobrazhenskaya, Elena, V
    Sokolova, Tatiana N.
    Broyde, Robert, V
    Imyanitov, Evgeny N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (03) : 439 - 450
  • [35] Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients
    Anna P. Sokolenko
    Tatiana V. Gorodnova
    Ilya V. Bizin
    Ekaterina Sh. Kuligina
    Khristina B. Kotiv
    Alexandr A. Romanko
    Tatiana I. Ermachenkova
    Alexandr O. Ivantsov
    Elena V. Preobrazhenskaya
    Tatiana N. Sokolova
    Robert V. Broyde
    Evgeny N. Imyanitov
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 439 - 450
  • [36] Chemotherapy response score after neoadjuvant chemotherapy in ovarian advanced high-grade serous carcinoma correlates with peritoneal cancer index
    Torralba, I.
    Martinez, M. A.
    Rodrigo, H.
    Quintero, A. M.
    Velasquez, J. R.
    Matheu, G.
    VIRCHOWS ARCHIV, 2018, 473 : S77 - S77
  • [37] Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer
    Ren, Yulan
    Shi, Tingyan
    Jiang, Rong
    Yin, Sheng
    Wang, Pan
    Zang, Rongyu
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (08) : 1398 - 1404
  • [38] Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer
    Natanzon, Yanina
    Earp, Madalene
    Cunningham, Julie M.
    Kalli, Kimberly R.
    Wang, Chen
    Armasu, Sebastian M.
    Larson, Melissa C.
    Bowtell, David D. L.
    Garsed, Dale W.
    Fridley, Brooke L.
    Winham, Stacey J.
    Goode, Ellen L.
    CANCER INFORMATICS, 2018, 17
  • [39] Association between chemotherapy response score (CRS) and tumour homologous recombination deficiency (tHRD) in women with newly diagnosed FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC)
    Britton, F.
    Zhou, C.
    Burghel, G. J.
    Schlecht, H.
    Desai, S.
    Barnes, B.
    Clamp, A. R.
    Hasan, J.
    Mitchell, C. L.
    Salih, Z.
    Edmondson, R.
    Evans, G. D.
    Jayson, G. C.
    Taylor, S.
    Morgan, R. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S584 - S584
  • [40] Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma
    Xie, Meng
    Zhang, Xuyin
    Jia, Zhan
    Ren, Yunyun
    Wang, Wenping
    ONCOLOGY LETTERS, 2014, 8 (04) : 1652 - 1656
12345